COMBINATION OF A PD-1 ANTAGONIST AND A LISTERIA-BASED VACCINE FOR TREATING PROSTATE CANCER

• 收藏
• 分享

专利权人:

Advaxis, Inc.;Merck Sharpe and Dohme Corp.

发明人:

Robert PETIT,David J. MAURO,Rodolfo F. PERINI

申请号：

US14802607

公开号：

US20160022814A1

申请日:

2015.07.17

申请国别(地区):

US

年份:

2016

代理人:

摘要：

The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a Listeria based strain that expresses prostate-tissue specific antigen (PSA), and the use of the combination therapies for the treatment of prostate cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/